Company Analysis

CryoPort, Inc. (CYRX)

Nasdaq: CYRX · Pharmaceutical Preparations · Brentwood, TN · filing with the SEC since 2005
Grade6.3
◀ Past 6.5● Present 7.0▶ Future 5.0
1 est.

Who runs CryoPort, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Shelton Jerrell
President, CEO. First filing Oct 2012, latest Aug 11, 2026, 24 filings in all.
Officers reporting now
4
of 8 people with a filing in the last fifteen months
Directors reporting now
4
11 people on the record since 2011
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Sawicki Mark WChief Scientific OfficerMar 2021Nov 12, 20263 · $200,000
Shelton JerrellPresident, CEOOct 2012Aug 11, 20263 · $500,000
Zecchini Edward JChief Digital and Tech OfficerOct 2013Jun 12, 20263 · $500,000
Stefanovich RobertChief Financial OfficerJul 2011Jun 8, 20264 · $3.1M
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Hancock Daniel MdirectorJan 2019Nov 12, 20261 · $1.5M
Baddour LindadirectorMar 2021Jun 9, 2026none
Hariri Robert JdirectorNov 2015Jun 8, 2026none
Mandalam RamkumardirectorJun 2014Jun 8, 20262 · $500,000
Earlier names on the record18, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CYRX · research, not advice